Clinical Trial Update: Alendronate to Reduce Pelvic Insufficiency Fractures in Cervical Cancer Patients Undergoing Chemoradiation [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial evaluating whether alendronate can reduce pelvic insufficiency fractures in cervical cancer patients undergoing chemoradiation, in Phase 1/Phas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• alendronate (alendronate)

Snippet

Sponsor: Dr. Itay GoorAryeh | Conditions: Cervix Cancer | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING